APA

Vandenhende M., Perrier A., Bonnet F., Lazaro E., Cazanave C., Reigadas S., Chêne G. & Morlat P. (20160907). Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study). : Antiviral therapy.

Chicago

Vandenhende Marie-Anne, Perrier Adélaïde, Bonnet Fabrice, Lazaro Estibaliz, Cazanave Charles, Reigadas Sandrine, Chêne Geneviève and Morlat Philippe. 20160907. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study). : Antiviral therapy.

Harvard

Vandenhende M., Perrier A., Bonnet F., Lazaro E., Cazanave C., Reigadas S., Chêne G. and Morlat P. (20160907). Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study). : Antiviral therapy.

MLA

Vandenhende Marie-Anne, Perrier Adélaïde, Bonnet Fabrice, Lazaro Estibaliz, Cazanave Charles, Reigadas Sandrine, Chêne Geneviève and Morlat Philippe. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study). : Antiviral therapy. 20160907.